Commodore Capital as of June 30, 2024
Portfolio Holdings for Commodore Capital
Commodore Capital holds 35 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Merus N V (MRUS) | 12.9 | $189M | 3.2M | 59.17 | |
| Nuvalent Inc-a (NUVL) | 7.7 | $113M | 1.5M | 75.86 | |
| Xenon Pharmaceuticals (XENE) | 7.3 | $107M | 2.8M | 38.99 | |
| Vaxcyte (PCVX) | 6.7 | $99M | 1.3M | 75.51 | |
| Enliven Therapeutics (ELVN) | 6.3 | $93M | 4.0M | 23.37 | |
| Vera Therapeutics Cl A (VERA) | 6.1 | $90M | 2.5M | 36.18 | |
| Cogent Biosciences (COGT) | 5.6 | $82M | 9.7M | 8.43 | |
| Soleno Therapeutics (SLNO) | 4.0 | $58M | 1.4M | 40.80 | |
| Celldex Therapeutics Com New (CLDX) | 3.6 | $53M | 1.4M | 37.01 | |
| Mind Medicine Mindmed Com New (MNMD) | 3.5 | $52M | 7.1M | 7.21 | |
| Rhythm Pharmaceuticals (RYTM) | 3.4 | $50M | 1.2M | 41.06 | |
| Arvinas Ord (ARVN) | 3.4 | $50M | 1.9M | 26.62 | |
| Spyre Therapeutics Com New (SYRE) | 3.2 | $47M | 2.0M | 23.51 | |
| Perspective Therapeutics Com New (CATX) | 3.2 | $46M | 4.7M | 9.97 | |
| Pharvaris N V (PHVS) | 2.3 | $34M | 1.8M | 18.80 | |
| Alkermes SHS (ALKS) | 2.3 | $33M | 1.4M | 24.10 | |
| Miragen Therapeutics (VRDN) | 2.2 | $33M | 2.5M | 13.01 | |
| Kura Oncology (KURA) | 2.2 | $33M | 1.6M | 20.59 | |
| Nkarta (NKTX) | 1.7 | $25M | 4.2M | 5.91 | |
| Celcuity (CELC) | 1.6 | $24M | 1.5M | 16.38 | |
| Third Harmonic Bio (THRD) | 1.4 | $20M | 1.5M | 13.00 | |
| Immunovant (IMVT) | 1.4 | $20M | 751k | 26.40 | |
| Abivax Sa Sponsored Ads (ABVX) | 1.2 | $17M | 1.3M | 13.22 | |
| Syndax Pharmaceuticals (SNDX) | 1.2 | $17M | 825k | 20.53 | |
| C4 Therapeutics Com Stk (CCCC) | 1.1 | $16M | 3.4M | 4.62 | |
| Oric Pharmaceuticals (ORIC) | 1.0 | $14M | 2.0M | 7.07 | |
| Apogee Therapeutics (APGE) | 0.8 | $11M | 290k | 39.35 | |
| Cabaletta Bio (CABA) | 0.6 | $8.2M | 1.1M | 7.48 | |
| Perceptive Cap Solutions Cor Cl A Ord Shs (PCSC) | 0.5 | $7.5M | 750k | 10.06 | |
| Neurogene (NGNE) | 0.5 | $7.3M | 200k | 36.39 | |
| Vistagen Therapeutics Ord (VTGN) | 0.4 | $5.5M | 1.6M | 3.48 | |
| Helix Acquisition Corp Ii Cl A Ord Shs (HLXB) | 0.3 | $5.1M | 500k | 10.22 | |
| Autolus Therapeutics Spon Ads (AUTL) | 0.3 | $4.1M | 1.2M | 3.48 | |
| Arca Biopharma (ABIO) | 0.1 | $1.6M | 414k | 3.83 | |
| Avalo Therapeutics Com New (AVTX) | 0.0 | $499k | 40k | 12.47 |
